BeOne insider plans sale of 132 ADS on NASDAQ
BeOne Medicines Ltd. (ONC) discloses that Titus Benjamin Ball plans to sell 132 American Depositary Shares (ADS) of the company under Rule 144, following restricted stock vesting under a registered plan.
Rhea-AI Filing Summary
BeOne Medicines Ltd. (ONC) discloses that Titus Benjamin Ball plans to sell 132 American Depositary Shares (ADS) of the company under Rule 144, following restricted stock vesting under a registered plan. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ. Over the prior three months, Titus Benjamin Ball reported sales of 169 ADS on June 11, 2026 for $43,466.56 and 136 ADS on June 8, 2026 for $36,900.64.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Rule 144 regulatory
restricted stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for BeOne Medicines Ltd. (ONC)?
How many BeOne Medicines (ONC) ADS are planned to be sold under this Form 144?
Which broker is handling the planned Rule 144 sale for ONC ADS?
What prior sales by Titus Benjamin Ball in ONC ADS are disclosed in the last 3 months?
What is the nature of the securities being sold for BeOne Medicines (ONC)?
AI-generated analysis. How Rhea-AI works. Not financial advice.